Lenacapavir Impurity 61 - Request Quote
Lenacapavir Impurity 61
| SZ CAT No: | SZ-L105063 |
| CAS No | NA |
| Mol.F. | C13H10BrClF2N2 |
| Mol.Wt. | 347.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lenacapavir Impurity 61 is chemically (S)-1-(3-bromo-6-chloropyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine compound with (S)-1-(6-bromo-3-chloropyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine (1:1). Lenacapavir Impurity 61 is supplied with detailed characterization data compliant with regulatory guideline. Lenacapavir Impurity 61 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lenacapavir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Lenacapavir Impurity 61
Purchase Lenacapavir Impurity 61
Lenacapavir Impurity 61 suppliers
Lenacapavir Impurity 61 manufacturers
Lenacapavir Impurity 61 price
Order Lenacapavir Impurity 61
Enquire Lenacapavir Impurity 61
Lenacapavir Impurity 61 cost
Lenacapavir Impurity 61 Supplier
Lenacapavir Impurity 61 Distributor
Lenacapavir Impurity 61 for Method Validation
Lenacapavir Reference Standard
Lenacapavir Impurity 61 for ANDA Filing
Lenacapavir Impurity 61 for Forced Degradation Studies
Lenacapavir Impurity 61 Identification Standards
Lenacapavir Impurity 61 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.